These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2909830)

  • 1. Hepatic metabolic alterations in rats treated with low-dose endotoxin and aspirin: an animal model of Reye's syndrome.
    Kilpatrick LE; Polin RA; Douglas SD; Corkey BE
    Metabolism; 1989 Jan; 38(1):73-7. PubMed ID: 2909830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reye syndrome model in rats: protection against liver abnormalities by L-carnitine and acetyl-L-carnitine.
    Visentin M; Bellasio R; Tacconi MT
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1069-75. PubMed ID: 7473134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.
    Osterloh J; Cunningham W; Dixon A; Combest D
    Med Toxicol Adverse Drug Exp; 1989; 4(4):272-94. PubMed ID: 2671597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between unusual hepatic acyl coenzyme A profiles and the pathogenesis of Reye syndrome.
    Corkey BE; Hale DE; Glennon MC; Kelley RI; Coates PM; Kilpatrick L; Stanley CA
    J Clin Invest; 1988 Sep; 82(3):782-8. PubMed ID: 3417871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free fatty acids in an animal model of Reye's syndrome.
    Deshmukh DR; Deshmukh GD; Shope TC; Radin NS
    Biochim Biophys Acta; 1983 Sep; 753(2):153-8. PubMed ID: 6615853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total and peroxisomal fatty acid oxidation by liver homogenates from autopsied Reye's and control subjects.
    Kang ES; Capaci MT; Sawhney B; Greenhaw J
    Biochem Med Metab Biol; 1986 Jun; 35(3):361-6. PubMed ID: 3521683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of beta-oxidation by 3-mercaptopropionic acid produces features of Reye's syndrome in perfused rat liver.
    Yamamoto M; Nakamura Y
    Gastroenterology; 1994 Aug; 107(2):517-24. PubMed ID: 8039627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ammonium chloride inhibits pyruvate oxidation in rat liver mitochondria: a possible cause of fatty liver in Reye's syndrome and urea cycle defects.
    Maddaiah VT; Kumbar U
    Clin Sci (Lond); 1994 Nov; 87(5):499-503. PubMed ID: 7874836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mitochondrial fatty acid oxidation in pentenoic acid-induced fatty liver. A possible model for Reye's syndrome.
    Thayer WS
    Biochem Pharmacol; 1984 Apr; 33(8):1187-94. PubMed ID: 6712730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium-chain and long-chain acyl CoA dehydrogenase deficiency: clinical, pathologic and ultrastructural differentiation from Reye's syndrome.
    Treem WR; Witzleben CA; Piccoli DA; Stanley CA; Hale DE; Coates PM; Watkins JB
    Hepatology; 1986; 6(6):1270-8. PubMed ID: 3793003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects.
    Gregersen N; Wintzensen H; Christensen SK; Christensen MF; Brandt NJ; Rasmussen K
    Pediatr Res; 1982 Oct; 16(10):861-8. PubMed ID: 7145508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza B virus model of Reye's syndrome in mice: the effect of aspirin.
    Davis LE; Green CL; Wallace JM
    Ann Neurol; 1985 Nov; 18(5):556-9. PubMed ID: 4073851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-existence of hepatitis A and adult Reye's syndrome.
    Duerksen DR; Jewell LD; Mason AL; Bain VG
    Gut; 1997 Jul; 41(1):121-4. PubMed ID: 9274483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is aspirin a cause of Reye's syndrome? A case against.
    Orlowski JP; Hanhan UA; Fiallos MR
    Drug Saf; 2002; 25(4):225-31. PubMed ID: 11994026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty liver and kidney syndrome in chickens as an animal model for Reye's syndrome.
    Awrich P; Madge GE; Wolf B
    J Pediatr Gastroenterol Nutr; 1983 Nov; 2(4):683-92. PubMed ID: 6644449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Reye's syndrome caused by augmented release of tumour necrosis factor?
    Larrick JW; Kunkel SL
    Lancet; 1986 Jul; 2(8499):132-3. PubMed ID: 2873400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acyl-CoA dehydrogenation deficiencies. Recent advances in the enzymic characterization and understanding of the metabolic and pathophysiological disturbances in patients with acyl-CoA dehydrogenation deficiencies.
    Gregersen N
    Scand J Clin Lab Invest Suppl; 1985; 174():1-60. PubMed ID: 3892650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine deficiency, organic acidemias, and Reye's syndrome.
    Stumpf DA; Parker WD; Angelini C
    Neurology; 1985 Jul; 35(7):1041-5. PubMed ID: 3892364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of mitochondrial functions by margosa oil: possible implications in the pathogenesis of Reye's syndrome.
    Koga Y; Yoshida I; Kimura A; Yoshino M; Yamashita F; Sinniah D
    Pediatr Res; 1987 Aug; 22(2):184-7. PubMed ID: 3658544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic effects of aspirin in fasting and fed subjects: relevance to the aetiology of Reye's syndrome.
    Williams FM; Ferner RE; Graham M; Blain PG; Alberti KG; Rawlins MD
    Eur J Clin Pharmacol; 1990; 38(5):519-21. PubMed ID: 2379539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.